← Browse by Condition
Medical Condition
metastatic gastric carcinoma
Total Trials
2
Recruiting Now
2
Trial Phases
Phase 1, Phase 2
NCT04704661 Phase 1
Recruiting
Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial
Enrollment
51 pts
Location
United States
Sponsor
National Cancer Institute (NCI...
NCT04550494 Phase 2
Recruiting
Measuring the Effects of Talazoparib in Patients With Advanced Cancer and DNA Repair Variations
Enrollment
36 pts
Location
United States
Sponsor
National Cancer Institute (NCI...